WAT earnings

MILFORD, Mass., April 20, 2026 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q1 2026 financial results conference call on Tuesday, May 5, 2026 at 8:30 a.m. Eastern Time. A live webcast of the presentation will be available on Waters Investor Relations website at https://ir.waters.com. A replay of the webcast will also be available until at least June 2, 2026, at midnight Eastern Time. About Waters CorporationWaters Corporation (NYSE:WAT) is a global leader in life sciences and diagnostics, dedicated to accelerating the benefits of pioneering science through analytical technologies, informatics, and service. With a focus on regulated, high-volume testing environments, our innova

Highlights Fourth Quarter 2025 Sales of $932 million landed at the high-end of reported sales growth guidance range; grew 7% as reported and 6% in constant currencyGrowth led by high single-digit constant currency growth in Pharma and Industrial end-markets, with broad-based growth across all regionsChemistry grew 12% in constant currency as new bioseparations products continued to experience significant customer demandInstruments grew 3% in constant currency, with high single-digit LC-MS growth partially offset by TA and transition to subscription model for EmpowerGAAP EPS of $3.77; non-GAAP EPS of $4.53 grew double digitsFull-Year 2025 Sales of $3,165 million grew 7% as reported and 7% in

Waters Corporation's Q4 2025 Financial Results Conference Call will now be held on Monday, February 9th, 2026 at 8:30am ET in conjunction with the expected close of the transaction MILFORD, Mass., Jan. 27, 2026 /PRNewswire/ -- Waters Corporation (NYSE:WAT) (the "Company" or "Waters") today announced that, at the Company's Special Meeting of Shareholders (the "Special Meeting") held today, Waters shareholders overwhelmingly voted to approve the issuance of shares of Waters common stock to shareholders of Becton, Dickinson and Company (NYSE:BDX) ("BD") in connection with the proposed combination of BD's Biosciences & Diagnostic Solutions business with Waters. 

MILFORD, Mass., Jan. 20, 2026 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q4 2025 financial results conference call on Thursday, February 12th, 2026 at 8:00 a.m. Eastern Time. A live webcast of the presentation will be available on Waters Investor Relations website at https://ir.waters.com. A replay of the webcast will also be available until at least March 12, 2026, at midnight Eastern Time. About Waters Corporation  Waters Corporation (NYSE:WAT) is a global leader in analytical instruments, separations technologies, and software, serving the life, materials, food, and environmental sciences for over 65 years. Our Company helps ensure the efficacy of medicines, the safety o

Highlights Sales of $800 million exceeded guidance; grew 8% as reported and 8% in constant currencyDelivered GAAP EPS of $2.50 and non-GAAP EPS of $3.40, which reflects strong, 16% growth in Adjusted Earnings Per Share that exceeded guidanceInstruments grew 6% in constant currency, led by high single-digit LC & MS growth, and TA Division returning to positive growthRecurring revenue grew 9% in constant currency; chemistry grew double digits, with strong uptake of new bioseparations productsIn constant currency, Pharma grew 11%, driven by broad-based growth across all regions, including double-digit growth in the AmericasRaising full-year 2025 constant currency sales growth guidance and raisi

MILFORD, Mass., Oct. 1, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q3 2025 financial results conference call on Tuesday, November 4th, 2025 at 8:00 a.m. Eastern Time. A live webcast of the presentation will be available on Waters Investor Relations website at https://ir.waters.com. A replay of the webcast will also be available until at least December 2nd, 2025, at midnight Eastern Time. About Waters Corporation  Waters Corporation (NYSE:WAT) is a global leader in analytical instruments, separations technologies, and software, serving the life, materials, food, and environmental sciences for over 65 years. Our Company helps ensure the efficacy of medicines, the safety

Highlights Sales of $771 million exceeded guidance range; grew 9% as reported and 8% in constant currencyGAAP EPS of $2.47 and non-GAAP EPS of $2.95, above mid-point of guidance range Instruments grew mid-single-digits in constant currency, led by high-single-digit LC and MS growth – with continued strength in instrument replacement, particularly among large pharma and CDMO customersRecurring revenue grew 11% in constant currency, with 9% service growth and double-digit chemistry growthIn constant currency, Pharma grew 11% and Industrial grew 6%, while Academic & Government declined 3%, performing better than expectedRaising full-year 2025 constant currency sales growth guidance to +5.5% to

Strong strategic fit that increases presence in multiple high-growth adjacencies and offers immediate commercial impact from Waters' proven execution model Doubles Waters' total addressable market to approximately $40 billion, with 5-7% annual growthCreates a combined company with pro forma expected 2025 sales of approximately $6.5 billion and adjusted EBITDA of approximately $2.0 billion Increases annual recurring revenue to over 70% with over 80% of revenue coming from iconic market-leading brandsAnticipate approximately $345 million in annualized EBITDA synergies by 2030, including $200 million of cost synergies by year three, and $290 million of revenue synergies by year five  Delivers a

MILFORD, Mass., July 11, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q2 2025 financial results conference call on Monday, August 4th, 2025 at 8:00 a.m. Eastern Time. A live webcast of the presentation will be available on Waters Investor Relations website at https://ir.waters.com. A replay of the webcast will also be available until at least September 2nd, 2025, at midnight Eastern Time. About Waters Corporation Waters Corporation (NYSE:WAT) is a global leader in analytical instruments, separations technologies, and software, serving the life, materials, food, and environmental sciences for over 65 years. Our Company helps ensure the efficacy of medicines, the safety of

Highlights Strong start to the year as first quarter 2025 sales of $662 million landed at the high-end of guidance range; grew 4% as reported and 7% in constant currencyResults led by instrument growth of 11% in constant currency, driven by strong momentum in Pharma and Industrial end marketsEarnings landed at the high-end of guidance range with GAAP EPS of $2.03 and non-GAAP EPS of $2.25Raising full-year constant currency sales growth guidance to +5.0% to +7.0%, given first quarter strengthRaising full-year non-GAAP EPS guidance to the range of $12.75 to $13.05, net of tariff impact, operational actions, and improvement in FXFirst Quarter 2025 MILFORD, Mass., May 6, 2025 /PRNewswire/ -- Wat

STAAR Surgical Company (NASDAQ:STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced changes to its Board of Directors. The Company announced that the Board appointed Louis E. Silverman, who served on the Company's Board from 2014-2022, as a director, effective April 24, 2025. The Company also announced that Aimee S. Weisner, who has served as a director since 2022, has chosen not to stand for re-election to the Board when her term expires at the Company's 2025 annual meeting of shareholders in June. In addition, the Company announced that Wei Jiang, who has served as a director since 2024, has agreed to

MILFORD, Mass., April 8, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q1 2025 financial results conference call on Tuesday, May 6th, 2025 at 8:00 a.m. Eastern Time. A live webcast of the presentation will be available on Waters Investor Relations website at https://ir.waters.com. A replay of the webcast will also be available until at least June 3rd, 2025, at midnight Eastern Time. About Waters Corporation  Waters Corporation (NYSE:WAT) is a global leader in analytical instruments, separations technologies, and software, serving the life, materials, food, and environmental sciences for over 65 years. Our Company helps ensure the efficacy of medicines, the safety of food

Highlights Fourth Quarter 2024 Sales of $873 million exceeded high-end of guidance range, grew 6% as reported and 8% in constant currencyInstruments grew 8% and recurring revenue grew 9% in constant currency, as growth accelerated across all three reported regionsPharma grew 10% in constant currency, reflecting stronger-than-expected year-end spending dynamics and broad-based growth across the Americas, Europe, and AsiaGAAP EPS of $3.88; non-GAAP EPS of $4.10 grew 13% as strong operational performance and better-than-expected sales volume offset foreign exchange headwinds Full-Year 2024 Sales exceeded guidance at $2,958 million, flat as reported and in organic constant currencyGAAP operating

MILFORD, Mass., Jan. 17, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q4 2024 financial results conference call live on Wednesday, February 12th, 2025 at 8:00 a.m. Eastern Time. A live webcast of the presentation will be available on Waters Investor Relations website at https://ir.waters.com. A replay of the webcast will also be available until at least March 12th, 2025, at midnight Eastern Time. About Waters Corporation Waters Corporation (NYSE:WAT), a global leader in analytical instruments and software, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, food, and environmental sciences for more than 65 years.

Highlights Sales of $740 million exceeded guidance, grew 4% as reported and 4% in constant currencyInstruments returned to growth; recurring revenue grew high single-digits in constant currencyAll reported regions returned to growth in the quarter; sales grew across all end markets, led by Pharma & IndustrialGAAP EPS of $2.71 and non-GAAP EPS of $2.93 significantly exceeded guidance, led by strong operational performance and better-than-expected market conditionsRaised full-year sales and EPS guidance, with 5% to 7% constant currency growth expected in the fourth quarterThird Quarter 2024 MILFORD, Mass., Nov. 1, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today announced its financial

MILFORD, Mass., Oct. 7, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q3 2024 financial results conference call live on Friday, November 1st, 2024 at 8:00 a.m. Eastern Time. A live webcast of the presentation will be available on Waters Investor Relations website at https://ir.waters.com. A replay of the webcast will also be available until at least November 29th, 2024, at midnight Eastern Time. About Waters Corporation Waters Corporation (NYSE:WAT), a global leader in analytical instruments and software, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, food, and environmental sciences for more than 65 years. W

Highlights Sales of $709 million exceeded guidance on a reported basis, declined 4% as reported and 4% in organic constant currencyGAAP EPS of $2.40; earnings exceeded guidance with non-GAAP EPS of $2.63, led by strong operational performanceBeat driven by better-than-expected performance in China, as well as higher-than-expected M&A contribution to overall sales from WyattEx-China organic constant currency sales growth as expected across Pharma, Industrial, and Academic & Government end marketsFull-year outlook reflects the potential for a more gradual market improvement in the second half of the year than previously anticipatedSecond Quarter 2024 MILFORD, Mass., July 31, 2024 /PRNewswire/

MILFORD, Mass., July 2, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q2 2024 financial results conference call live on Wednesday, July 31st, 2024 at 8:00 a.m. Eastern Time. A live webcast of the presentation will be available on Waters Investor Relations website at https://ir.waters.com. A replay of the webcast will also be available until at least August 28th, 2024, at midnight Eastern Time. About Waters Corporation Waters Corporation (NYSE:WAT), a global leader in analytical instruments and software, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, food, and environmental sciences for more than 65 years. Wit

Highlights Sales of $637 million at the high-end of guidance, declined 7% as reported and 9% in organic constant currencyGAAP EPS of $1.72; earnings well above guidance, with non-GAAP EPS of $2.21Operational excellence drove gross margin expansion of 40 basis points and adjusted operating margin expansion of 20 basis pointsStrong operating cash flow generation at $263 million; free cash flow of $234 million was 37% of sales Full-year guidance maintained at -0.5% to +1.5% organic constant currency sales growth and non-GAAP EPS of $11.75 to $12.05First Quarter 2024 MILFORD, Mass., May 7, 2024 /PRNewswire/ -- Waters Corporation (NYSE: WAT) today announced its financial results for the first qua

MILFORD, Mass., April 11, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q1 2024 financial results conference call live on Tuesday, May 7th, 2024 at 8:00 a.m. Eastern Time. A live webcast of the presentation will be available on Waters Investor Relations website at https://ir.waters.com. A replay of the webcast will also be available until at least June 4th, 2024, at midnight Eastern Time. About Waters Corporation Waters Corporation (NYSE:WAT), a global leader in analytical instruments and software, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, food, and environmental sciences for more than 65 years. With app

Highlights Fourth Quarter 2023 Sales of $819 million declined 4.5% as reported and 8% in organic constant currency, in line with guidanceOperational excellence drove gross margin expansion of 170 basis points and adjusted operating margin expansion of 120 basis pointsNon-GAAP EPS of $3.62 at the high end of guidance; GAAP EPS of $3.65Full-Year 2023 Strong execution in tough market conditions delivered sales of $2,956 million, a decline of 0.5% as reported and 2% in organic constant currency, as expectedWyatt acquisition delivered an on-target M&A contribution of 2.5% to salesGross margin expanded 160 basis points to 59.6% and adjusted operating margin expanded 70 basis points to 30.9%MILFORD

MILFORD, Mass., Jan. 18, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q4 2023 financial results conference call live on Tuesday, February 6th, 2024 at 8:00 a.m. Eastern Time. A live webcast of the presentation will be available on Waters Investor Relations website at https://ir.waters.com. A replay of the webcast will also be available until at least March 5th, 2024, at midnight Eastern Time. About Waters Corporation  Waters Corporation (NYSE:WAT), a global leader in analytical instruments and software, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, food, and environmental sciences for more than 60 years. Wi

MILFORD, Mass., Oct. 10, 2023 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q3 2023 financial results conference call live on Tuesday, November 7th, 2023 at 8:00 a.m. Eastern Time. A live webcast of the presentation will be available on Waters' Investor Relations website at https://ir.waters.com. A replay of the webcast will also be available until at least November 21, 2023, at midnight Eastern Time. About Waters Corporation  Waters Corporation (NYSE:WAT), a global leader in analytical instruments and software, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, and food sciences for over 60 years. With approximately

Highlights Sales of $741 million grew 4% as reported and 3% in organic constant currencyStrength led by double-digit growth in Industrial and Academic & GovernmentOperational excellence added 230 basis points of gross margin expansionHigh single-digit organic constant currency growth in the U.S. and Europe was partially offset by Pharma weakness in ChinaWyatt acquisition ahead of expectations with 2% sales contribution in the quarterMILFORD, Mass., Aug. 2, 2023 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today announced its financial results for the second quarter of 2023. Sales for the second quarter of 2023 were $741 million, an increase of 4% as reported, compared to sales of $714 milli

MILFORD, Mass., July 5, 2023 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q2 2023 financial results conference call live on Wednesday, August 2nd, 2023, at 8:00 a.m. Eastern Time. A live webcast of the presentation will be available on Waters' Investor Relations website at https://ir.waters.com. A replay of the webcast will also be available until at least August 16th, 2023, at midnight Eastern Time. About Waters Corporation Waters Corporation (NYSE:WAT), a global leader in analytical instruments and software, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, and food sciences for more than 60 years. With more than 8

Highlights First quarter sales of $685 million declined 1% as reported and grew 3% in constant currencyGrowth in broader Asia and Europe offset by weakness in China and the U.S.Instrument revenues declined 3% in constant currency as Pharma customers recalibrated and delayed spendingRecurring revenues grew high-single-digits in constant currency, with continued strength supported by commercial initiativesStrong two-year compound annual sales growth rate of 6.1% as reported and 9.4% in constant currencyFirst Quarter 2023 MILFORD, Mass., May 9, 2023 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today announced its financial results for the first quarter of 2023.

Waters Corporation (NYSE:WAT) will hold its Q1 2023 financial results conference call live on Tuesday, May 9th 2023 at 8:00 a.m. Eastern Time. A live webcast of the presentation will be available on Waters' investor relations website at https://ir.waters.com. A replay of the webcast will also be available until at least May 23rd, 2023, at midnight eastern time. About Waters Corporation Waters Corporation (NYSE:WAT), a global leader in analytical instruments and software, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, and food sciences for more than 60 years. With more than 8,200 employees worldwide, Waters operates directly

Highlights Fourth quarter sales of $859 million grew 3% as reported and 9% in constant currency Quarter led by double-digit instrument sales growth. Overall, Industrial grew mid-teens, while growth in all end markets remained robust Strong finish to the year delivered sales growth of 7% as reported and 12% in constant currency for 2022, with double-digit growth across all end-markets and regions After delivering strong commercial execution and revitalizing its portfolio, Waters is entering the next phase of its execution strategy with the acquisition of Wyatt Technology Waters Corporation (NYSE:WAT) today announced its financial results for the fourth quarter and full-year 2022.

News Summary: Accelerates next phase of Waters' strategy for growth and value creation through increased exposure in attractive, high-growth adjacent markets. Wyatt is a rapidly growing leader in light scattering technology and advanced software solutions with significant exposure to bioanalytical characterization including cell and gene therapies. Transaction is immediately accretive to revenue growth and margin profile, with adjusted EPS accretion beginning in Q1 2024 and high single-digit plus ROIC by year five. Waters Corporation (NYSE:WAT) today announced it has entered into an agreement to acquire Wyatt Technology, a pioneer in innovative light scattering and field-flow fracti

Waters Corporation (NYSE:WAT) will hold its Q4 2022 financial results conference call live on Wednesday, February 15th 2023 at 8:00 a.m. eastern time. A live webcast of the presentation will be available on Waters' investor relations website at https://ir.waters.com. A replay of the webcast will also be available until at least March 1st, 2023, at midnight eastern time. About Waters Corporation Waters Corporation (NYSE:WAT), a global leader in analytical instruments and software, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, and food sciences for more than 60 years. With more than 7,800 employees worldwide, Waters operates d

Highlights Sales of $709 million grew 7% as reported and 15% in constant currency Instrument sales grew 21% in constant currency, with strong growth across LC, MS, and TA product lines Industrial grew 22% in constant currency, with broad strength across food and environmental, chemical analysis, and TA All major geographies grew double-digits in constant currency, led by 23% growth in China Recurring revenues grew double-digits in constant currency, supported by commercial initiatives Waters Corporation (NYSE:WAT) today announced its financial results for the third quarter of 2022. "Our team is consistently delivering outstanding results in resilient markets. This is reflected

Waters Corporation (NYSE:WAT) will hold its Q3 2022 financial results conference call live on Tuesday, November 1st 2022 at 8:00 a.m. eastern time. A live webcast of the presentation will be available on Waters' investor relations website at https://ir.waters.com. A replay of the webcast will also be available until at least November 15th, 2022, at midnight eastern time. About Waters Corporation Waters Corporation (NYSE:WAT), a global leader in analytical instruments and software, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, and food sciences for more than 60 years. With more than 7,800 employees worldwide, Waters operates

Highlights Sales of $714 million grew 5% as reported and 10% in constant currency Continued strong momentum as instrument sales grew 12% in constant currency, with double-digit growth across LC, MS and TA product lines Broad-based performance across all end-markets and major geographies, led by mid-teens growth in the U.S. and 9% constant currency growth in China Recurring revenues grew high-single-digits as strong commercial execution continued GAAP EPS of $2.72; non-GAAP EPS of $2.75, a 6% increase from prior year Waters Corporation (NYSE:WAT) today announced its financial results for the second quarter of 2022. "Our team's strong focus on execution continued to deliver excel

Waters Corporation (NYSE:WAT) will hold its Q2 2022 financial results conference call live on Tuesday, August 2nd 2022 at 8:00 a.m. eastern time. A live webcast of the presentation will be available on Waters' investor relations website at https://ir.waters.com. A replay of the webcast will also be available until at least August 16th 2022 at midnight eastern time. About Waters Corporation Waters Corporation (NYSE:WAT), a global leader in analytical instruments and software, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, and food sciences for more than 60 years. With more than 7,800 employees worldwide, Waters operates direct

Highlights Sales of $691 million grew 13% as reported and 16% in constant currency Transformation on track with strong commercial momentum, operational performance, and innovation Instrument sales grew 26% in constant currency, with strong growth across LC, MS and TA product lines All end-markets grew, with pharmaceutical and industrial both up high-teens Broad-based sales growth across all geographies, led by U.S. which grew 28% and China grew 17% in constant currency GAAP EPS of $2.62; non-GAAP EPS of $2.80, a 22% increase from prior year Waters Corporation (NYSE:WAT) today announced its financial results for the first quarter of 2022. "Our teams continue to deliver excelle

Waters Corporation (NYSE:WAT) will webcast its Q1 2022 financial results conference call live on Tuesday, May 3rd 2022 at 8:00 a.m. eastern time. A live webcast of the presentation will be available on Waters' investor relations website at https://ir.waters.com. A replay of the webcast will also be available until at least May 17th 2022 at midnight eastern time. About Waters Corporation Waters Corporation (NYSE:WAT), the world's leading specialty measurement company, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, and food sciences for more than 60 years. With more than 7,400 employees worldwide, Waters operates directly in 35

Fourth quarter sales of $836 million grew 8% in constant currency, 6% as reported Quarter led by double-digit instrument sales growth, with momentum increasing on a two year stacked basis into year-end Transformation on track with strong growth in 2021 as instrument sales and recurring revenues grew across all regions, delivering 16% growth in constant currency, 18% as reported Full-year GAAP EPS of $11.17; non-GAAP EPS of $11.20, a 24% increase from prior year Waters Corporation (NYSE:WAT) today announced fourth quarter 2021 sales of $836 million, an increase of 6% as reported and 8% in constant currency, compared to sales of $787 million for the fourth quarter of 2020. On a GAAP

Waters Corporation (NYSE:WAT) will webcast its Q4 2021 financial results conference call live on Tuesday, February 1st 2022 at 8:00 a.m. eastern time. A live webcast of the presentation will be available on Waters' investor relations website at https://ir.waters.com. A replay of the webcast will also be available until at least February 15th, 2022 at midnight eastern time. About Waters Corporation Waters Corporation (NYSE:WAT), the world's leading specialty measurement company, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, and food sciences for more than 60 years. With more than 7,400 employees worldwide, Waters operates dir

Sales of $659 million grew 11% as reported and in constant currency GAAP EPS of $2.60; non-GAAP EPS of $2.66, a 23% increase from prior year Growth led by strong performance in pharmaceutical and industrial end markets Double-digit growth in both instrument sales and recurring revenues Balanced customer demand across the Americas, Europe and Asia Waters Corporation (NYSE:WAT) today announced third quarter 2021 sales of $659 million, an 11% increase as reported, compared to sales of $594 million for the third quarter of 2020. Foreign currency translation benefited sales growth by less than 1% for the quarter. On a GAAP basis, diluted earnings per share (EPS) for the third quarter

Waters Corporation (NYSE:WAT) will webcast its Q3 2021 financial results conference call live on Tuesday, November 2nd, 2021 at 8:00 a.m. eastern time. Interested investors can access the live webcast of the presentation on Waters' investor relations website at https://ir.waters.com. A replay of the webcast will be available until November 16th, 2021 at midnight eastern time. About Waters Corporation Waters Corporation (NYSE:WAT), the world's leading specialty measurement company, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, and food sciences for more than 60 years. With more than 7,400 employees worldwide, Waters operates

Sales of $682 million grew 31% as reported and 27% in constant currency GAAP EPS of $2.69; non-GAAP EPS of $2.60, a 24% increase from prior year Broad-based commercial momentum in pharmaceutical and industrial end markets Continued strength in core and new product instrument and chemistry sales Strong and balanced customer demand across key regions and geographies Waters Corporation (NYSE:WAT) today announced second quarter 2021 sales of $682 million, a 31% increase as reported, compared to sales of $520 million for the second quarter of 2020. Foreign currency translation benefited sales growth by approximately 4% for the quarter. On a GAAP basis, diluted earnings per share (EPS